Sato, T.; Kawasaki, Y.; Maekawa, M.; Takasaki, S.; Morozumi, K.; Sato, M.; Shimada, S.; Kawamorita, N.; Yamashita, S.; Mitsuzuka, K.;
et al. Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma. Metabolites 2021, 11, 1.
https://doi.org/10.3390/metabo11010001
AMA Style
Sato T, Kawasaki Y, Maekawa M, Takasaki S, Morozumi K, Sato M, Shimada S, Kawamorita N, Yamashita S, Mitsuzuka K,
et al. Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma. Metabolites. 2021; 11(1):1.
https://doi.org/10.3390/metabo11010001
Chicago/Turabian Style
Sato, Tomonori, Yoshihide Kawasaki, Masamitsu Maekawa, Shinya Takasaki, Kento Morozumi, Masahiko Sato, Shuichi Shimada, Naoki Kawamorita, Shinichi Yamashita, Koji Mitsuzuka,
and et al. 2021. "Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma" Metabolites 11, no. 1: 1.
https://doi.org/10.3390/metabo11010001
APA Style
Sato, T., Kawasaki, Y., Maekawa, M., Takasaki, S., Morozumi, K., Sato, M., Shimada, S., Kawamorita, N., Yamashita, S., Mitsuzuka, K., Mano, N., & Ito, A.
(2021). Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma. Metabolites, 11(1), 1.
https://doi.org/10.3390/metabo11010001